Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018474002> ?p ?o ?g. }
- W2018474002 endingPage "2965" @default.
- W2018474002 startingPage "2959" @default.
- W2018474002 abstract "Background. Recombinant human Interleukin-2 (IL-2) has been effective at inducing measurable antitumor responses in adults with renal cell carcinoma and melanoma. It also is being tested as adjuvant therapy for patients with acute myeloid leukemia after autologous bone marrow transplantation. Methods. The authors tested IL-2 in a pediatric Phase II trial using a regimen that has antitumor effects in adults and was proven to be tolerated acceptably in a prior Phase I pediatric trial. Thirty-eight patients were entered into this study of whom 36 received IL–2 and were evaluable (20 with sarcoma, 9 with neuroblastoma, 5." @default.
- W2018474002 created "2016-06-24" @default.
- W2018474002 creator A5001697191 @default.
- W2018474002 creator A5011569932 @default.
- W2018474002 creator A5019914745 @default.
- W2018474002 creator A5031252498 @default.
- W2018474002 creator A5058268746 @default.
- W2018474002 creator A5060957245 @default.
- W2018474002 creator A5062595575 @default.
- W2018474002 creator A5088589506 @default.
- W2018474002 date "1995-06-15" @default.
- W2018474002 modified "2023-10-16" @default.
- W2018474002 title "A phase II trial of human recombinant lnterleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study" @default.
- W2018474002 cites W1550885672 @default.
- W2018474002 cites W1769520442 @default.
- W2018474002 cites W1868595314 @default.
- W2018474002 cites W1967884480 @default.
- W2018474002 cites W1983910040 @default.
- W2018474002 cites W1990078051 @default.
- W2018474002 cites W2001132572 @default.
- W2018474002 cites W2023296863 @default.
- W2018474002 cites W2028681561 @default.
- W2018474002 cites W2029409133 @default.
- W2018474002 cites W2033981370 @default.
- W2018474002 cites W2046024886 @default.
- W2018474002 cites W2073133806 @default.
- W2018474002 cites W2074387411 @default.
- W2018474002 cites W2158391991 @default.
- W2018474002 cites W2167447755 @default.
- W2018474002 cites W2170678234 @default.
- W2018474002 doi "https://doi.org/10.1002/1097-0142(19950615)75:12<2959::aid-cncr2820751225>3.0.co;2-r" @default.
- W2018474002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7773948" @default.
- W2018474002 hasPublicationYear "1995" @default.
- W2018474002 type Work @default.
- W2018474002 sameAs 2018474002 @default.
- W2018474002 citedByCount "55" @default.
- W2018474002 countsByYear W20184740022012 @default.
- W2018474002 countsByYear W20184740022014 @default.
- W2018474002 countsByYear W20184740022015 @default.
- W2018474002 countsByYear W20184740022016 @default.
- W2018474002 countsByYear W20184740022017 @default.
- W2018474002 countsByYear W20184740022018 @default.
- W2018474002 countsByYear W20184740022019 @default.
- W2018474002 countsByYear W20184740022020 @default.
- W2018474002 countsByYear W20184740022021 @default.
- W2018474002 crossrefType "journal-article" @default.
- W2018474002 hasAuthorship W2018474002A5001697191 @default.
- W2018474002 hasAuthorship W2018474002A5011569932 @default.
- W2018474002 hasAuthorship W2018474002A5019914745 @default.
- W2018474002 hasAuthorship W2018474002A5031252498 @default.
- W2018474002 hasAuthorship W2018474002A5058268746 @default.
- W2018474002 hasAuthorship W2018474002A5060957245 @default.
- W2018474002 hasAuthorship W2018474002A5062595575 @default.
- W2018474002 hasAuthorship W2018474002A5088589506 @default.
- W2018474002 hasBestOaLocation W20184740021 @default.
- W2018474002 hasConcept C121332964 @default.
- W2018474002 hasConcept C126322002 @default.
- W2018474002 hasConcept C142424586 @default.
- W2018474002 hasConcept C142724271 @default.
- W2018474002 hasConcept C143998085 @default.
- W2018474002 hasConcept C2776715637 @default.
- W2018474002 hasConcept C2777472916 @default.
- W2018474002 hasConcept C2777658100 @default.
- W2018474002 hasConcept C2778256501 @default.
- W2018474002 hasConcept C2779338263 @default.
- W2018474002 hasConcept C2911091166 @default.
- W2018474002 hasConcept C502942594 @default.
- W2018474002 hasConcept C54355233 @default.
- W2018474002 hasConcept C71924100 @default.
- W2018474002 hasConcept C81885089 @default.
- W2018474002 hasConcept C86803240 @default.
- W2018474002 hasConcept C87355193 @default.
- W2018474002 hasConcept C90924648 @default.
- W2018474002 hasConceptScore W2018474002C121332964 @default.
- W2018474002 hasConceptScore W2018474002C126322002 @default.
- W2018474002 hasConceptScore W2018474002C142424586 @default.
- W2018474002 hasConceptScore W2018474002C142724271 @default.
- W2018474002 hasConceptScore W2018474002C143998085 @default.
- W2018474002 hasConceptScore W2018474002C2776715637 @default.
- W2018474002 hasConceptScore W2018474002C2777472916 @default.
- W2018474002 hasConceptScore W2018474002C2777658100 @default.
- W2018474002 hasConceptScore W2018474002C2778256501 @default.
- W2018474002 hasConceptScore W2018474002C2779338263 @default.
- W2018474002 hasConceptScore W2018474002C2911091166 @default.
- W2018474002 hasConceptScore W2018474002C502942594 @default.
- W2018474002 hasConceptScore W2018474002C54355233 @default.
- W2018474002 hasConceptScore W2018474002C71924100 @default.
- W2018474002 hasConceptScore W2018474002C81885089 @default.
- W2018474002 hasConceptScore W2018474002C86803240 @default.
- W2018474002 hasConceptScore W2018474002C87355193 @default.
- W2018474002 hasConceptScore W2018474002C90924648 @default.
- W2018474002 hasIssue "12" @default.
- W2018474002 hasLocation W20184740021 @default.
- W2018474002 hasLocation W20184740022 @default.
- W2018474002 hasOpenAccess W2018474002 @default.
- W2018474002 hasPrimaryLocation W20184740021 @default.
- W2018474002 hasRelatedWork W1974317126 @default.
- W2018474002 hasRelatedWork W2021744816 @default.